| Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer G Wei, P An, KA Vaid, I Nasser, P Huang, L Tan, S Zhao, D Schuppan, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 318 (1 …, 2020 | 78 | 2020 |
| Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma J Liao, H Jin, S Li, L Xu, Z Peng, G Wei, J Long, Y Guo, M Kuang, Q Zhou, ... Journal of Experimental & Clinical Cancer Research 38, 1-13, 2019 | 57 | 2019 |
| Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c. Abcb4-/-mouse model of PFIC3 G Wei, J Cao, P Huang, P An, D Badlani, KA Vaid, S Zhao, DQH Wang, ... Journal of hepatology 74 (6), 1416-1428, 2021 | 54 | 2021 |
| A novel non‐bile acid FXR agonist EDP‐305 potently suppresses liver injury and fibrosis without worsening of ductular reaction P An, G Wei, P Huang, W Li, X Qi, Y Lin, KA Vaid, J Wang, S Zhang, Y Li, ... Liver International 40 (7), 1655-1669, 2020 | 54 | 2020 |
| Sublethal heat treatment of hepatocellular carcinoma promotes intrahepatic metastasis and stemness in a VEGFR1-dependent manner L Tan, S Chen, G Wei, Y Li, J Liao, H Jin, Y Zou, M Huang, Z Peng, Y Guo, ... Cancer Letters 460, 29-40, 2019 | 53 | 2019 |
| The ectonucleotidase ENTPD1/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis ZW Peng, S Rothweiler, G Wei, N Ikenaga, SB Liu, DY Sverdlov, KA Vaid, ... Hepatology communications 1 (9), 957-972, 2017 | 40 | 2017 |
| Autocrine STIP1 signaling promotes tumor growth and is associated with disease outcome in hepatocellular carcinoma Z Chen, L Xu, T Su, Z Ke, Z Peng, N Zhang, S Peng, Q Zhang, G Liu, ... Biochemical and biophysical research communications 493 (1), 365-372, 2017 | 39 | 2017 |
| FGF14 functions as a tumor suppressor through inhibiting PI3K/AKT/mTOR pathway in colorectal cancer T Su, L Huang, N Zhang, S Peng, X Li, G Wei, E Zhai, Z Zeng, L Xu Journal of Cancer 11 (4), 819, 2020 | 24 | 2020 |
| Nab-paclitaxel and gemcitabine plus camrelizumab and radiotherapy versus nab-paclitaxel and gemcitabine alone for locally advanced pancreatic adenocarcinoma: a prospective … S Chen, J Li, A Dong, Z Liu, M Zhu, M Jin, G Wei, S Wu, Y Wang, Y Chen, ... Journal of Hematology & Oncology 16 (1), 26, 2023 | 10 | 2023 |
| Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model Z Wang, H Xiao, G Wei, N Zhang, M Wei, Z Chen, Z Peng, S Peng, S Qiu, ... BMC cancer 18, 1-8, 2018 | 9 | 2018 |
| Automated whole slide image analysis for a translational quantification of liver fibrosis C Serdjebi, K Bertotti, P Huang, G Wei, D Skelton-Badlani, IA Leclercq, ... Scientific reports 12 (1), 17935, 2022 | 7 | 2022 |
| Heme oxygenase-1 mitigates liver injury and fibrosis via modulation of LNX1/Notch1 pathway in myeloid cells G Canesin, L Feldbrügge, G Wei, L Janovicova, M Janikova, E Csizmadia, ... Iscience 25 (9), 2022 | 7 | 2022 |
| Anti-PD-1 antibody in combination with radiotherapy as first-line therapy for unresectable intrahepatic cholangiocarcinoma M Zhu, M Jin, X Zhao, S Shen, Y Chen, H Xiao, G Wei, Q He, B Li, Z Peng BMC medicine 22 (1), 165, 2024 | 4 | 2024 |
| A novel small molecule LOXL2 inhibitor PAT-1251 potently suppresses hepatic stellate cell activation and liver fibrosis in mouse models of biliary disease P An, KA Vaid, G Wei, Y Lin, G Bain, Y Popov Hepatology 66, 213A, 2017 | 3 | 2017 |
| ASK1/p38 axis inhibition blocks the release of mitochondrial “danger signals” from hepatocytes and suppresses progression to cirrhosis and liver cancer Z Peng, G Wei, P Huang, H Matta, W Gao, P An, S Zhao, Y Lin, L Tan, ... Hepatology 80 (2), 346-362, 2024 | 1 | 2024 |
| ASK1/p38 AXIS INHIBITION BLOCKS THE RELEASE OF MITOCHONDRIAL" DANGER SIGNALS" FROM HEPATOCYTES AND SUPPRESSES PROGRESSION TO CIRRHOSIS AND LIVER CANCER Z Peng, G Wei, P Huang, P An, S Zhao, Y Lin, L Tan, K Vaid, ... Hepatology 78, S1514-S1514, 2023 | 1 | 2023 |
| IDDF2019-ABS-0113 FGF14 is a functional tumor suppressor through inhibiting PI3K/AKT/mTOR pathway in colorectal cancer T Su, N Zhang, L Huang, G Wei, S Peng, Z Zeng Gut 68 (Suppl 1), A15-A15, 2019 | 1 | 2019 |
| MDR3/ABCB4 mRNA therapy for treating progressive familial intrahepatic cholestasis 3 (PFIC3) J Cao, G Wei, J Zhuo, Y Lin, A Frassetto, V Presnyak, S Gandham, S Hua, ... MOLECULAR THERAPY 27 (4), 358-359, 2019 | 1 | 2019 |
| A novel FXR agonist EDP-305 potently suppresses liver injury and fibrosis in mouse models of biliary and metabolic liver disease P An, KA Vaid, G Wei, MD Chau, Y Li, YS Or, LJ Jiang, YV Popov birth 6, 12, 2017 | 1 | 2017 |
| CA19-9-related macrophage polarization drives poor prognosis in HCC after immune checkpoint inhibitor treatment T Du, J Zou, Y Yang, H Xie, H Pang, W Zhuang, S Wang, G Wei Frontiers in Oncology 14, 1528138, 2025 | | 2025 |
